NSF International’s Medical Devices Group to Focus on Consulting and Training Services in Europe

YORK, UK – NSF International’s medical devices program in Europe is shifting senior leadership roles and responsibilities after a subsidiary of the global public health organization withdrew its notified body designation application for European In-Vitro Diagnostic and Medical Device Regulations. The move by NSF Certification Ireland Ltd. paves the way for the NSF’S medical device regulation experts to provide consulting and training services through NSF International in Europe.

“Within the health products and pharma biotech sectors, NSF’s greatest strengths are in the areas of consulting and training. Consistent with our public health mission, we believe we can have the greatest impact on health and safety by focusing on science-based risk management solutions,” said James Pink, Executive Vice President of Consulting Services at NSF International, Medical Devices.

To support the move, several NSF Certification Ireland Ltd. leaders are taking on new roles within NSF International’s medical devices group:

James Pink now serves as Executive Vice President of Consulting Services

NSF International is a global, independent organization that facilitates standards development, and tests and certifies products for the health sciences, water, food and consumer goods industries to minimize adverse health effects and protect the environment. Founded in 1944, NSF is committed to protecting human health and safety worldwide. With operations in more than 175 countries, NSF International is a Pan American Health Organization/World Health Organization (WHO) Collaborating Center on Food Safety, Water Quality and Indoor Environment.